Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy.

OBJECTIVES The aim of this study was to describe a new familial cardiac phenotype and to elucidate the electrophysiological mechanism responsible for the disease. BACKGROUND Mutations in several genes encoding ion channels, especially SCN5A, have emerged as the basis for a variety of inherited cardiac arrhythmias. METHODS Three unrelated families comprising 21 individuals affected by multifocal ectopic Purkinje-related premature contractions (MEPPC) characterized by narrow junctional and rare sinus beats competing with numerous premature ventricular contractions with right and/or left bundle branch block patterns were identified. RESULTS Dilated cardiomyopathy was identified in 6 patients, atrial arrhythmias were detected in 9 patients, and sudden death was reported in 5 individuals. Invasive electrophysiological studies demonstrated that premature ventricular complexes originated from the Purkinje tissue. Hydroquinidine treatment dramatically decreased the number of premature ventricular complexes. It normalized the contractile function in 2 patients. All the affected subjects carried the c.665G>A transition in the SCN5A gene. Patch-clamp studies of resulting p.Arg222Gln (R222Q) Nav1.5 revealed a net gain of function of the sodium channel, leading, in silico, to incomplete repolarization in Purkinje cells responsible for premature ventricular action potentials. In vitro and in silico studies recapitulated the normalization of the ventricular action potentials in the presence of quinidine. CONCLUSIONS A new SCN5A-related cardiac syndrome, MEPPC, was identified. The SCN5A mutation leads to a gain of function of the sodium channel responsible for hyperexcitability of the fascicular-Purkinje system. The MEPPC syndrome is responsive to hydroquinidine.

[1]  A. Wilde,et al.  Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. , 2008, Trends in cardiovascular medicine.

[2]  A. Wilde,et al.  Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. , 2009, Heart rhythm.

[3]  E. Génin,et al.  Estimating the age of rare disease mutations: the example of Triple-A syndrome , 2004, Journal of Medical Genetics.

[4]  J. Caldwell,et al.  SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. , 2011, Journal of the American College of Cardiology.

[5]  H. Wellens,et al.  Radiofrequency Catheter Ablation of Idiopathic Ventricular Tachycardia Originating in the Anterior Fascicle of the Left Bundle Branch , 1996, Journal of cardiovascular electrophysiology.

[6]  A. Gramolini,et al.  Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death , 2003, Nature.

[7]  T. Jespersen,et al.  Inherited Cardiac Diseases Caused by Mutations in the Nav1.5 Sodium Channel , 2010, Journal of cardiovascular electrophysiology.

[8]  Michael Christiansen,et al.  The genetic basis of long QT and short QT syndromes: A mutation update , 2009, Human mutation.

[9]  Henggui Zhang,et al.  Optimal velocity and safety of discontinuous conduction through the heterogeneous Purkinje-ventricular junction. , 2009, Biophysical journal.

[10]  E. Kaufman.  Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. , 2009, Heart rhythm.

[11]  B. Fermini,et al.  Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. , 1995, The Journal of pharmacology and experimental therapeutics.

[12]  14-3-3 Is a Regulator of the Cardiac Voltage-Gated Sodium Channel Nav1.5 , 2006, Circulation research.

[13]  D. Roden.  Human genomics and its impact on arrhythmias. , 2004, Trends in cardiovascular medicine.

[14]  D. Escande,et al.  Novel SCN5A Mutation Leading Either to Isolated Cardiac Conduction Defect or Brugada Syndrome in a Large French Family , 2001, Circulation.

[15]  R. Winslow,et al.  A computational model of the human left-ventricular epicardial myocyte. , 2004, Biophysical journal.

[16]  N. Norton,et al.  Rare Variant Mutations in Pregnancy-Associated or Peripartum Cardiomyopathy , 2010, Circulation.

[17]  Jeffrey L. Anderson,et al.  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.

[18]  H. Wichmann,et al.  Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. , 2008, The Journal of clinical investigation.

[19]  D. Roden,et al.  Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. , 1996, Circulation.

[20]  Yuan-Ping Pang,et al.  ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating , 2004, Nature Genetics.

[21]  B Brinkmann,et al.  Mutation rate in human microsatellites: influence of the structure and length of the tandem repeat. , 1998, American journal of human genetics.

[22]  D. Escande,et al.  Phosphatidylinositol‐4,5‐bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage‐gated potassium channels: a functional homology between voltage‐gated and inward rectifier K+ channels , 2003, The EMBO journal.

[23]  G. Kay,et al.  Ventricular Tachycardia Originating From the Posterior Papillary Muscle in the Left Ventricle: A Distinct Clinical Syndrome , 2008, Circulation. Arrhythmia and electrophysiology.

[24]  A. George,et al.  Divergent Biophysical Defects Caused by Mutant Sodium Channels in Dilated Cardiomyopathy With Arrhythmia , 2008, Circulation research.

[25]  J. Salata,et al.  Effects of Quinidine on Action Potentials and Ionic Currents in Isolated Canine Ventricular Myocytes , 1988, Circulation research.

[26]  G. Steinbeck,et al.  Different Forms of Ventricular Tachycardia Involving the Left Anterior Fascicle in Nonischemic Cardiomyopathy: Critical Sites of the Reentrant Circuit in Low‐Voltage Areas , 2009, Journal of cardiovascular electrophysiology.

[27]  L. Mestroni,et al.  SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia , 2004, Circulation.

[28]  Lin Wu,et al.  Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine. , 2008, Heart rhythm.

[29]  A. Wilde,et al.  Cardiac conduction defects associate with mutations in SCN5A , 1999, Nature Genetics.

[30]  J. Towbin,et al.  An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. , 2010, Heart rhythm.

[31]  I. V. Van Gelder,et al.  Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. , 1999, Cardiovascular research.

[32]  W. Giles,et al.  Quinidine-induced inhibition of transient outward current in cardiac muscle. , 1987, The American journal of physiology.

[33]  James P. Keener,et al.  Mathematical physiology , 1998 .

[34]  C. Wippermann,et al.  Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe , 2000, Heart.

[35]  Ferhaan Ahmad,et al.  Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. , 2008, Journal of molecular and cellular cardiology.

[36]  R. Hershberger,et al.  Coding Sequence Mutations Identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 Patients with Familial or Idiopathic Dilated Cardiomyopathy , 2008, Clinical and translational science.

[37]  T. Zimmer,et al.  SCN5A channelopathies--an update on mutations and mechanisms. , 2008, Progress in biophysics and molecular biology.

[38]  D. Snyders,et al.  Effects of quinidine on the sodium current of guinea pig ventricular myocytes. Evidence for a drug-associated rested state with altered kinetics. , 1990, Circulation research.

[39]  D. Escande,et al.  Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease. , 2003, Journal of the American College of Cardiology.

[40]  J. Papp,et al.  Comparison of the Effect of Class IA Antiarrhythmic Drugs on Transmembrane Potassium Currents in Rabbit Ventricular Myocytes , 2003, Journal of cardiovascular pharmacology and therapeutics.

[41]  Michael C Sanguinetti,et al.  Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain. , 2003, Molecular pharmacology.

[42]  Y. Iesaka,et al.  Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. , 2000, Journal of the American College of Cardiology.

[43]  W. Stevenson,et al.  Identification and Ablation of Three Types of Ventricular Tachycardia Involving the His‐Purkinje System in Patients with Heart Disease , 2004, Journal of cardiovascular electrophysiology.

[44]  D DiFrancesco,et al.  A model of cardiac electrical activity incorporating ionic pumps and concentration changes. , 1985, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[45]  Ana Morales,et al.  SCN5A Rare Variants in Familial Dilated Cardiomyopathy Decrease Peak Sodium Current Depending on the Common Polymorphism H558R and Common Splice Variant Q1077del , 2010, Clinical and translational science.

[46]  G. Hindricks,et al.  Catheter Ablation of Recurrent Scar‐Related Ventricular Tachycardia Using Electroanatomical Mapping and Irrigated Ablation Technology: Results of the Prospective Multicenter Euro‐VT‐Study , 2010, Journal of cardiovascular electrophysiology.

[47]  D. Roden,et al.  Quinidine delays IK activation in guinea pig ventricular myocytes. , 1988, Circulation research.

[48]  N. Makita.  Phenotypic overlap of cardiac sodium channelopathies: individual-specific or mutation-specific? , 2009, Circulation journal : official journal of the Japanese Circulation Society.